For the quarter ending 2026-03-31, SNSE has $205,381K in assets. $14,191K in debts. $152,325K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 152,325 | 8,668 | 10,562 | 12,557 |
| Marketable securities | 50,468 | 12,516 | 14,479 | 16,071 |
| Prepaid expenses | 974 | 231 | 496 | 828 |
| Other current assets | 465 | 92 | 248 | 116 |
| Total current assets | 204,232 | 21,507 | 25,785 | 29,572 |
| Right of use assets - operating leases, net | 913 | 1,294 | 1,668 | 2,034 |
| Right of use assets - financing leases, net | 0 | 1 | 6 | 10 |
| Total property and equipment | 650 | 622 | 622 | - |
| Less accumulated depreciation and amortization | 581 | 540 | 510 | - |
| Property and equipment, net | 69 | 82 | 112 | 143 |
| Other non-current assets | 167 | 18 | 18 | 24 |
| Total assets | 205,381 | 22,902 | 27,589 | 31,783 |
| Accounts payable and accrued expenses | 8,982 | 1,481 | 1,405 | 1,135 |
| Compensation and employee benefits liabilities | 4,169 | 1,320 | 1,156 | 775 |
| Operating lease liabilities, current | 1,021 | 1,370 | 1,682 | 1,622 |
| Financing lease liabilities, current | 18 | 80 | 193 | 341 |
| Total current liabilities | 14,190 | 4,251 | 4,436 | 3,873 |
| Operating lease liabilities, non-current | 0 | 59 | 146 | 592 |
| Financing lease liabilities, non-current | - | 0 | 0 | 4 |
| Other non-current liabilities | 1 | - | - | - |
| Total liabilities | 14,191 | 4,310 | 4,582 | 4,469 |
| Series b redeemable convertible preferred stock, 0.0001 par value 25,045 and 0 shares authorized as of march 31, 2026 and december 31, 2025, respectively 24,937 and 0 shares issued and outstanding as of march 31, 2026, and december 31, 2025, respectively liquidation value of 0 as of march 31, 2026 | 328,476 | - | - | - |
| Additional paid-in capital | 316,111 | 301,728 | 301,431 | 301,177 |
| Accumulated deficit | -453,373 | -283,137 | -278,421 | -273,852 |
| Accumulated other comprehensive (loss) income | -24 | 1 | -3 | -11 |
| Total stockholders' (deficit) equity | -137,286 | 18,592 | 23,007 | 27,314 |
| Total liabilities, redeemable convertible preferred stock, and stockholders' (deficit) equity | 205,381 | 22,902 | 27,589 | 31,783 |
Sensei Biotherapeutics, Inc. (SNSE)
Sensei Biotherapeutics, Inc. (SNSE)